Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

VitreoRetinal Technologies (aka VRT) is Profiled in this Database

Updated At 27 May, 2010

Start Free 7 Day Trial Now
Partial description of this company
Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of VitreoRetinal Technologies (aka VRT) plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About VitreoRetinal Technologies (aka VRT)

Technology/product details


Our Clients